Bronchiectasis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Bronchiectasis}} | {{Bronchiectasis}} | ||
{{CMG}}; {{AE}} {{HQ}} | |||
==Overview== | ==Overview== | ||
To reduce the impact of the disease, patients should lead a healthy lifestyle, use prophylactic treatment when needed, do vaccinations, and practice physiotherapy strategies. | To reduce the impact of the [[disease]], patients should lead a [[Health|healthy]] lifestyle, use prophylactic treatment when needed, do [[vaccinations]], and practice [[Physical therapy|physiotherapy]] strategies. | ||
==Bronchiectasis Secondary Prevention== | ==Bronchiectasis Secondary Prevention== | ||
====Healthy Lifestyle==== | ====Healthy Lifestyle==== | ||
*Smoking cessation | *[[Smoking]] cessation | ||
*Exercise | *[[Physical exercise|Exercise]] | ||
*Maintain a healthy BMI | *Maintain a healthy [[Body mass index|BMI]] | ||
====Prophylactic Treatment==== | ====Prophylactic Treatment==== | ||
*National guidelines recommend that patients suffering from three or more exacerbations per year, should be considered for long-term antibiotics.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | *National guidelines recommend that patients suffering from three or more exacerbations per year, should be considered for long-term [[Antibiotic|antibiotics]].<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
*[[Macrolide]] daily or three times weekly | *[[Macrolide]] daily or three times weekly | ||
:*[[Macrolides]] exhibit anti-bacterial and [[immunomodulatory]] effects.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | :*[[Macrolides]] exhibit anti-bacterial and [[immunomodulatory]] effects.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
*[[Amoxicillin]] 500 mg twice daily or doxycycline 100 mg twice daily for patients who are not candidates for long-term macrolide administration | *[[Amoxicillin]] 500 mg twice daily or [[doxycycline]] 100 mg twice daily for patients who are not candidates for long-term [[macrolide]] administration | ||
====Vaccination==== | ====Vaccination==== | ||
*There has been some evidence to support that the yearly influenza vaccine reduces morbidity, mortality, and healthcare costs with high-risk patients | *There has been some evidence to support that the yearly [[influenza]] vaccine reduces [[morbidity]], mortality, and [[Health care|healthcare]] costs with high-risk patients | ||
====Physiotherapy Strategies==== | ====Physiotherapy Strategies==== | ||
*Airway | *[[Airway]] clearance | ||
:*Postural | :*Postural drainage | ||
:*Autogenic | :*Autogenic drainage | ||
:*Active | :*Active cycle of [[breathing]] techniques | ||
:*Positive | :*Positive expiratory pressure (PEP) | ||
:*Oscillatory PEP devices | :*Oscillatory PEP devices | ||
:*High-frequency chest wall [[percussion]] | :*High-frequency [[chest]] wall [[percussion]] | ||
*Pulmonary Rehabilitation | *[[Lung|Pulmonary]] [[Rehabilitation medicine|rehabilitation]] | ||
:*Exercise training | :*[[Physical exercise|Exercise]] training | ||
:*Nutritional counseling | :*[[Nutrition|Nutritional]] counseling | ||
:* | :*[[Education]] of the patient's [[disease]] and how to manage it | ||
:*Techniques on how to conserve energy | :*Techniques on how to conserve [[energy]] | ||
:*Strategies on breathing | :*Strategies on [[breathing]] | ||
:*Psychological counseling | :*[[Psychology|Psychological]] [[counseling]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| |||
| |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Pulmonology]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 20:43, 29 July 2020
|
Bronchiectasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bronchiectasis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Bronchiectasis secondary prevention |
|
Risk calculators and risk factors for Bronchiectasis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
To reduce the impact of the disease, patients should lead a healthy lifestyle, use prophylactic treatment when needed, do vaccinations, and practice physiotherapy strategies.
Bronchiectasis Secondary Prevention
Healthy Lifestyle
Prophylactic Treatment
- National guidelines recommend that patients suffering from three or more exacerbations per year, should be considered for long-term antibiotics.[1]
- Macrolide daily or three times weekly
- Macrolides exhibit anti-bacterial and immunomodulatory effects.[1]
- Amoxicillin 500 mg twice daily or doxycycline 100 mg twice daily for patients who are not candidates for long-term macrolide administration
Vaccination
- There has been some evidence to support that the yearly influenza vaccine reduces morbidity, mortality, and healthcare costs with high-risk patients
Physiotherapy Strategies
- Airway clearance
- Postural drainage
- Autogenic drainage
- Active cycle of breathing techniques
- Positive expiratory pressure (PEP)
- Oscillatory PEP devices
- High-frequency chest wall percussion
- Exercise training
- Nutritional counseling
- Education of the patient's disease and how to manage it
- Techniques on how to conserve energy
- Strategies on breathing
- Psychological counseling
References
- ↑ 1.0 1.1 McDonnell MJ, Ward C, Lordan JL, Rutherford RM (2013). "Non-cystic fibrosis bronchiectasis". QJM. 106 (8): 709–15. doi:10.1093/qjmed/hct109. PMID 23728208.
Template:WH Template:WS